Centrality analysis

Dysregulation of TFDP1 and of the cell cycle pathway in high-grade glioblastoma multiforme: a bioinformatic analysis

X. Lu, Lv, X. D., Ren, Y. H., Yang, W. D., Li, Z. B., Zhang, L., Bai, X. F., Lu, X., Lv, X. D., Ren, Y. H., Yang, W. D., Li, Z. B., Zhang, L., and Bai, X. F., Dysregulation of TFDP1 and of the cell cycle pathway in high-grade glioblastoma multiforme: a bioinformatic analysis, vol. 15, p. -, 2016.

Despite extensive research, the prognosis of high-grade glioblastoma multiforme (GBM) has improved only slightly because of the limited response to standard treatments. Recent advances (discoveries of molecular biomarkers) provide new opportunities for the treatment of GBM. The aim of the present study was to identify diagnostic biomarkers of high-grade GBM. First, we combined 3 microarray expression datasets to screen them for genes differentially expressed in patients with high-grade GBM relative to healthy subjects.

Selecting key genes associated with osteosarcoma based on a differential expression network

Y. B. Wang, Jia, N., Xu, C. M., Zhao, L., Zhao, Y., Wang, X., and Jia, T. H., Selecting key genes associated with osteosarcoma based on a differential expression network, vol. 14, pp. 17708-17717, 2015.

Despite recent advances in osteosarcoma diagnosis and therapy, much remains unclear about the molecular mechanisms involved in the disorder, and the discovery of novel drug-targeted genes is essential. We explored the potential molecular mechanisms and target genes involved in the development and progression of osteosarcoma. First, we identified the differentially expressed genes in osteosarcoma patients and matching normal controls. We then constructed a differential expression network based on differential and non-differential interactions.

Subscribe to Centrality analysis